This report contains market size and forecasts of Breast Cancer Liquid Biopsy in Global, including the following market information:
Global Breast Cancer Liquid Biopsy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Breast Cancer Liquid Biopsy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Liquid Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Liquid Biopsy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Breast Cancer Liquid Biopsy Market Segment Percentages, By Type, 2020 (%)
Circulating Tumor Cells (CTCs)
Cell-Free DNA (CfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
China Breast Cancer Liquid Biopsy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Breast Cancer Liquid Biopsy Market Segment Percentages, By Application, 2020 (%)
Hospitals
Diagnostic Centers
Laboratories
Global Breast Cancer Liquid Biopsy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Breast Cancer Liquid Biopsy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Breast Cancer Liquid Biopsy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Breast Cancer Liquid Biopsy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
QIAGEN
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini Silicon Biosystems
Genomic Health
Thermo Fisher Scientific
Illumina
Biocept
Trovagene
Guardant Health
RainDance Technologies
MDx Health
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Breast Cancer Liquid Biopsy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Breast Cancer Liquid Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Liquid Biopsy Overall Market Size
2.1 Global Breast Cancer Liquid Biopsy Market Size: 2021 VS 2027
2.2 Global Breast Cancer Liquid Biopsy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Breast Cancer Liquid Biopsy Players in Global Market
3.2 Top Global Breast Cancer Liquid Biopsy Companies Ranked by Revenue
3.3 Global Breast Cancer Liquid Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Liquid Biopsy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Breast Cancer Liquid Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Liquid Biopsy Players in Global Market
3.6.1 List of Global Tier 1 Breast Cancer Liquid Biopsy Companies
3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Liquid Biopsy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Breast Cancer Liquid Biopsy Market Size Markets, 2021 & 2027
4.1.2 Circulating Tumor Cells (CTCs)
4.1.3 Cell-Free DNA (CfDNA)
4.1.4 Extracellular Vesicles (EVs)
4.1.5 Other Circulating Biomarkers
4.2 By Type - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
4.2.1 By Type - Global Breast Cancer Liquid Biopsy Revenue, 2016-2021
4.2.2 By Type - Global Breast Cancer Liquid Biopsy Revenue, 2022-2027
4.2.3 By Type - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Breast Cancer Liquid Biopsy Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Laboratories
5.2 By Application - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
5.2.1 By Application - Global Breast Cancer Liquid Biopsy Revenue, 2016-2021
5.2.2 By Application - Global Breast Cancer Liquid Biopsy Revenue, 2022-2027
5.2.3 By Application - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Breast Cancer Liquid Biopsy Market Size, 2021 & 2027
6.2 By Region - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
6.2.1 By Region - Global Breast Cancer Liquid Biopsy Revenue, 2016-2021
6.2.2 By Region - Global Breast Cancer Liquid Biopsy Revenue, 2022-2027
6.2.3 By Region - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Breast Cancer Liquid Biopsy Revenue, 2016-2027
6.3.2 US Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.3.3 Canada Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.3.4 Mexico Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Breast Cancer Liquid Biopsy Revenue, 2016-2027
6.4.2 Germany Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.4.3 France Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.4.4 U.K. Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.4.5 Italy Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.4.6 Russia Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.4.7 Nordic Countries Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.4.8 Benelux Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Breast Cancer Liquid Biopsy Revenue, 2016-2027
6.5.2 China Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.5.3 Japan Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.5.4 South Korea Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.5.5 Southeast Asia Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.5.6 India Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Breast Cancer Liquid Biopsy Revenue, 2016-2027
6.6.2 Brazil Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.6.3 Argentina Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Breast Cancer Liquid Biopsy Revenue, 2016-2027
6.7.2 Turkey Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.7.3 Israel Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.7.4 Saudi Arabia Breast Cancer Liquid Biopsy Market Size, 2016-2027
6.7.5 UAE Breast Cancer Liquid Biopsy Market Size, 2016-2027
7 Players Profiles
7.1 QIAGEN
7.1.1 QIAGEN Corporate Summary
7.1.2 QIAGEN Business Overview
7.1.3 QIAGEN Breast Cancer Liquid Biopsy Major Product Offerings
7.1.4 QIAGEN Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.1.5 QIAGEN Key News
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Corporate Summary
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Major Product Offerings
7.2.4 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.2.5 Roche Diagnostics Key News
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Corporate Summary
7.3.2 Bio-Rad Laboratories Business Overview
7.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Major Product Offerings
7.3.4 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.3.5 Bio-Rad Laboratories Key News
7.4 Myriad Genetics
7.4.1 Myriad Genetics Corporate Summary
7.4.2 Myriad Genetics Business Overview
7.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Major Product Offerings
7.4.4 Myriad Genetics Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.4.5 Myriad Genetics Key News
7.5 Menarini Silicon Biosystems
7.5.1 Menarini Silicon Biosystems Corporate Summary
7.5.2 Menarini Silicon Biosystems Business Overview
7.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Major Product Offerings
7.5.4 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.5.5 Menarini Silicon Biosystems Key News
7.6 Genomic Health
7.6.1 Genomic Health Corporate Summary
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Breast Cancer Liquid Biopsy Major Product Offerings
7.6.4 Genomic Health Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.6.5 Genomic Health Key News
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Corporate Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Major Product Offerings
7.4.4 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.7.5 Thermo Fisher Scientific Key News
7.8 Illumina
7.8.1 Illumina Corporate Summary
7.8.2 Illumina Business Overview
7.8.3 Illumina Breast Cancer Liquid Biopsy Major Product Offerings
7.8.4 Illumina Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.8.5 Illumina Key News
7.9 Biocept
7.9.1 Biocept Corporate Summary
7.9.2 Biocept Business Overview
7.9.3 Biocept Breast Cancer Liquid Biopsy Major Product Offerings
7.9.4 Biocept Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.9.5 Biocept Key News
7.10 Trovagene
7.10.1 Trovagene Corporate Summary
7.10.2 Trovagene Business Overview
7.10.3 Trovagene Breast Cancer Liquid Biopsy Major Product Offerings
7.10.4 Trovagene Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.10.5 Trovagene Key News
7.11 Guardant Health
7.11.1 Guardant Health Corporate Summary
7.11.2 Guardant Health Business Overview
7.11.3 Guardant Health Breast Cancer Liquid Biopsy Major Product Offerings
7.11.4 Guardant Health Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.11.5 Guardant Health Key News
7.12 RainDance Technologies
7.12.1 RainDance Technologies Corporate Summary
7.12.2 RainDance Technologies Business Overview
7.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Major Product Offerings
7.12.4 RainDance Technologies Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.12.5 RainDance Technologies Key News
7.13 MDx Health
7.13.1 MDx Health Corporate Summary
7.13.2 MDx Health Business Overview
7.13.3 MDx Health Breast Cancer Liquid Biopsy Major Product Offerings
7.13.4 MDx Health Breast Cancer Liquid Biopsy Revenue in Global (2016-2021)
7.13.5 MDx Health Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Breast Cancer Liquid Biopsy Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Liquid Biopsy Market Drivers in Global Market
Table 3. Breast Cancer Liquid Biopsy Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Liquid Biopsy in Global Market
Table 5. Top Breast Cancer Liquid Biopsy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Breast Cancer Liquid Biopsy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Breast Cancer Liquid Biopsy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Breast Cancer Liquid Biopsy Product Type
Table 9. List of Global Tier 1 Breast Cancer Liquid Biopsy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Liquid Biopsy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type